Valeant Pharmaceuticals share price up, raises takeover bid for Allergan to $53 billion
June 1, 2014 8:26 am
Valeant Pharmaceuticals International Inc raised its takeover offer for Botox maker Allergan Inc for the second time this week in an ongoing effort to secure a deal that would value Allergan at about $53.3 billion. Valeant has teamed up with Bill Ackman, whose hedge fund Pershing Square Capital Management LP owns a 9.7% stake in […] Read more